124 related articles for article (PubMed ID: 1653153)
1. [Modern problems of the pharmacology of nootropic agents: the status and outlook].
Voronina TA
Farmakol Toksikol; 1991; 54(2):6-11. PubMed ID: 1653153
[TBL] [Abstract][Full Text] [Related]
2. "Endogenous ligands" of benzodiazepine receptors, their structural analogs. Development of new psychotropic drugs.
Akhundov RA; Voronina TA; Valdman AV
Acta Physiol Pharmacol Bulg; 1985; 11(4):3-11. PubMed ID: 3012945
[TBL] [Abstract][Full Text] [Related]
3. [Nootropic preparations, the achievements and new problems].
Voronina TA; Seredenin SB
Eksp Klin Farmakol; 1998; 61(4):3-9. PubMed ID: 9783097
[TBL] [Abstract][Full Text] [Related]
4. GABA(A) receptor subtypes as targets for neuropsychiatric drug development.
Korpi ER; Sinkkonen ST
Pharmacol Ther; 2006 Jan; 109(1-2):12-32. PubMed ID: 15996746
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of tolerance to benzodiazepine receptor ligands.
Płaźnik A
Pol J Pharmacol; 1995; 47(6):489-99. PubMed ID: 8868371
[TBL] [Abstract][Full Text] [Related]
6. [Current trends in the search for membrane-active compounds and membrane-active compound-based drugs].
Smirnov LD; Diumaev KM
Vestn Akad Med Nauk SSSR; 1984; (11):89-94. PubMed ID: 6397001
[No Abstract] [Full Text] [Related]
7. [Quantitative pharmaco-EEG study of nootropics].
Kinoshita T
Seishin Shinkeigaku Zasshi; 1990; 92(5):255-76. PubMed ID: 2119513
[TBL] [Abstract][Full Text] [Related]
8. [Current information on benzodiazepine-GABA-receptor complexes--perspectives on the development of highly specific neuropsychotropic drugs].
Langnickel R; Bluth R; Ott T
Pharmazie; 1986 Oct; 41(10):689-94. PubMed ID: 3029786
[No Abstract] [Full Text] [Related]
9. [Prospects of the search for novel anxiolytics].
Voronina TA; Seredenin SB
Eksp Klin Farmakol; 2002; 65(5):4-17. PubMed ID: 12596506
[TBL] [Abstract][Full Text] [Related]
10. [Spectra of pharmacological activity of the endogenous ligands of the benzodiazepine receptors and their structural analogs].
Akhundov RA; Voronina TA
Farmakol Toksikol; 1984; 47(4):25-8. PubMed ID: 6090200
[TBL] [Abstract][Full Text] [Related]
11. [Current problems and the outlook for the development of chronopharmacology].
Arushanian EB
Farmakol Toksikol; 1989; 52(5):10-6. PubMed ID: 2689207
[TBL] [Abstract][Full Text] [Related]
12. Anticonvulsant and antiepileptogenic effects of GABAA receptor ligands in pentylenetetrazole-kindled mice.
Hansen SL; Sperling BB; Sánchez C
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):105-13. PubMed ID: 14687864
[TBL] [Abstract][Full Text] [Related]
13. [3 new GABA-ergics: research on their possible site of action].
Vamvakidès A
Agressologie; 1985 Jun; 26(7):591-4. PubMed ID: 2994504
[No Abstract] [Full Text] [Related]
14. [General patterns in the action of psychotropic agents].
Karkishchenko NN
Farmakol Toksikol; 1986; 49(5):45-50. PubMed ID: 3533617
[TBL] [Abstract][Full Text] [Related]
15. Nootropic drugs reduce immobility in behavioural despair test in mice.
Schmidt J
Biomed Biochim Acta; 1984; 43(11):1295-9. PubMed ID: 6442578
[TBL] [Abstract][Full Text] [Related]
16. Effects of hippocampal injections of a novel ligand selective for the alpha 5 beta 2 gamma 2 subunits of the GABA/benzodiazepine receptor on Pavlovian conditioning.
Bailey DJ; Tetzlaff JE; Cook JM; He X; Helmstetter FJ
Neurobiol Learn Mem; 2002 Jul; 78(1):1-10. PubMed ID: 12071663
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the effects on learning and memory of nootropic drugs and central stimulants when applied together.
Petkov VD; Konstantinova E; Petkov VV; Lazarova M; Petkova B
Acta Physiol Pharmacol Bulg; 1991; 17(4):17-26. PubMed ID: 1688150
[TBL] [Abstract][Full Text] [Related]
18. 4-quinolone derivatives: high-affinity ligands at the benzodiazepine site of brain GABA A receptors. synthesis, pharmacology, and pharmacophore modeling.
Lager E; Andersson P; Nilsson J; Pettersson I; Nielsen EØ; Nielsen M; Sterner O; Liljefors T
J Med Chem; 2006 Apr; 49(8):2526-33. PubMed ID: 16610795
[TBL] [Abstract][Full Text] [Related]
19. [Ion channels of neuronal electro- and chemoexcitable membranes as the targets psychopharmacological drug action].
Abramets II
Farmakol Toksikol; 1983; 46(6):99-105. PubMed ID: 6140187
[No Abstract] [Full Text] [Related]
20. Novel 3-iodo-8-ethoxypyrazolo[5,1-c][1,2,4]benzotriazine 5-oxide as promising lead for design of alpha5-inverse agonist useful tools for therapy of mnemonic damage.
Guerrini G; Ciciani G; Cambi G; Bruni F; Selleri S; Besnard F; Montali M; Martini C; Ghelardini C; Galeotti N; Costanzo A
Bioorg Med Chem; 2007 Apr; 15(7):2573-86. PubMed ID: 17306981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
